Cleared Traditional

K940986 - FLUTTER

K940986 is the FDA 510(k) clearance for FLUTTER by Varioraw SA. It is a Class 2 Anesthesiology device (product code BYI) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K940986 · Varioraw SA · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1994
Decision
84d
Days
Class 2
Risk

K940986 is an FDA 510(k) clearance for the FLUTTER(R). Classified as Percussor, Powered-electric (product code BYI), Class II - Special Controls.

Submitted by Varioraw SA (Brunswick, US). The FDA issued a Cleared decision on May 24, 1994 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5665 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Varioraw SA devices

Submission Details

510(k) Number K940986 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 01, 1994
Decision Date May 24, 1994
Days to Decision 84 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 140d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code BYI Percussor, Powered-electric
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5665
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.